$HALO
Halozyme Therapeutics, Inc.
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateHalozyme Therapeutics, Inc.
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
Why is HALO up today? It is at $112.98 (+3.01%), and our scanner flagged it 82 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment HALO spikes, and full due diligence on HALO — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $HALO 82 times in the last 30 days. Create a free account to track $HALO, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on HALO from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for HALO today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Latest filing8-KOther Material EventSep 18, 2026 · 2 days ago| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Posard Matthew L. Director | Sold (automatic/other) | -19K 0.02% of company | sold 24% | 59K | $2.0M at $106.13 | Sep 16, 26 |
Torley Helen Officer | Sold (automatic/other) | -20K 0.02% of company | sold 2.5% | 768K | $2.1M at $107.15 | Sep 11, 26 |
Torley Helen Officer | Other | 20K 0.02% of company | added 2.6% | 788K | $368K at $18.41 | Sep 11, 26 |
Torley Helen Officer | Sold (automatic/other) | -20K 0.02% of company | sold 2.5% | 768K | $2.1M at $107.01 | Sep 10, 26 |
Torley Helen Officer | Other | 20K 0.02% of company | added 2.6% | 788K | $368K at $18.41 | Sep 10, 26 |
Torley Helen Officer | Sold (automatic/other) | -20K 0.02% of company | sold 2.5% | 768K | $2.1M at $107.22 | Sep 9, 26 |
Torley Helen Officer | Other | 20K 0.02% of company | added 2.6% | 788K | $368K at $18.41 | Sep 9, 26 |
Appelhans Dannielle Director | Acquired (grant/award) | +1K | n/a | 1K | n/a | Sep 1, 26 |
Torley Helen Officer | Sold (automatic/other) | -20K 0.02% of company | sold 2.5% | 768K | $2.1M at $106.36 | Aug 19, 26 |
Torley Helen Officer | Other | 20K 0.02% of company | added 2.6% | 788K | $368K at $18.41 | Aug 19, 26 |
Torley Helen Officer | Sold (automatic/other) | -20K 0.02% of company | sold 2.5% | 768K | $2.1M at $103.08 | Aug 18, 26 |
Torley Helen Officer | Other | 20K 0.02% of company | added 2.6% | 788K | $368K at $18.41 | Aug 18, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.


Comparable names in biological products, (no diagnostic substances), closest in size first.
Here is the latest on HALO from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for HALO today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
HALO last traded at $112.98, up 3.01% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Halozyme Therapeutics, Inc. (HALO) is next expected to report earnings on Monday, November 2, 2026, about 43 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The HALO Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged HALO 82 times in the last 30 days.
HALO (Halozyme Therapeutics, Inc.) trades on XNAS, with a market cap of about $12.76B in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge HALO for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$HALO discussion
Sign in to ask a question or join the discussion.